QCLVX
Price
$34.81
Change
+$0.20 (+0.58%)
Updated
Oct 14 closing price
Net Assets
1.96B
VIVAX
Price
$72.80
Change
+$0.15 (+0.21%)
Updated
Oct 15 closing price
Net Assets
207.8B
Interact to see
Advertisement

QCLVX vs VIVAX

Header iconQCLVX vs VIVAX Comparison
Open Charts QCLVX vs VIVAXBanner chart's image
Federated Hermes MDT Large Cap Value C
Price$34.81
Change+$0.20 (+0.58%)
VolumeN/A
Net Assets1.96B
Vanguard Value Index I
Price$72.80
Change+$0.15 (+0.21%)
VolumeN/A
Net Assets207.8B
QCLVX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
QCLVX vs. VIVAX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCLVX is a Hold and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. QCLVX (1.96B). VIVAX pays higher dividends than QCLVX: VIVAX (1.97) vs QCLVX (0.20). QCLVX was incepted earlier than VIVAX: QCLVX (8 years) vs VIVAX (33 years). QCLVX (1.92) is less costly to investors than VIVAX (0.17). QCLVX is a more actively managed with annual turnover of: 69.00 vs. VIVAX (9.00). QCLVX has a lower initial minimum investment than VIVAX: QCLVX (1500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 5.61 vs. QCLVX (-2.28). VIVAX return over 5 years is better than : 72.28 vs. QCLVX (33.41).
QCLVXVIVAXQCLVX / VIVAX
Total Expense Ratio1.810.171,065%
Annual Report Gross Expense Ratio1.920.171,129%
Fund Existence8 years33 years-
Gain YTD12.75010.056127%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B208B1%
Annual Yield % from dividends0.201.9710%
Returns for 1 year-2.285.61-41%
Returns for 3 years31.5947.9266%
Returns for 5 years33.4172.2846%
Returns for 10 yearsN/A129.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHTDF2.40N/A
N/A
Sinopharm Group Co. Ltd.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
CLYYF0.41N/A
N/A
Celyad Oncology SA
RCRRF49.03-1.70
-3.35%
Recruit Holdings Co., Ltd.
VRDR0.10N/A
-4.34%
Verde Resources, Inc.